NS-5 Resveratrol Quercetin d-Tocotrienol
 ‡MicroRNAs Pre-dose Post-dose Post-dose Post-dose Post-dose
    % % % % %
I Cardiovascular disease:
a Down-regulation
1 miRNA-7a 100 43 ± 1.02** 74 ± 1.83** 78 ± 1.76** 61 ± 0.66**
2 miRNA-10b 100 34 ± 2.40** 87 ± 0.64* 91 ±1.13* 42 ± 4.17**
3 miRNA-15a 100 68 ± 2.07** 92 ± 1.89* 67 ± 1.49** 87 ± 0.24*
4 miRNA-16 100 61 ± 1.66** 87 ± 0.44* 74 ± 1.16** 71 ± 1.24**
5 miRNA-20a 100 61 ± 0.97** 83 ± 0.75* 93 ± 0.98* 71 ± 1.07**
6 miRNA-21 100 43 ± 2.14** 79 ± 0.62** 50 ± 1.50** 40 ± 2.06**
7 miRNA-29a 100 83 ± 0.97* 87 ± 2.32* 74 ± 1.09** 84 ± 0.41**
8 miRNA-92a 100 36 ± 2.25** 79 ± 0.88** 41 ± 1.68** 55 ± 1.91**
9 miRNA-126a 100 71 ± 0.79** 91 ± 1.45* 67 ± 6.08** 82 ± 0.52*
10 miRNA-133a 100 35 ± 1.52** 84 ± 1.52* 44 ± 2.44** 72 ± 0.76**
11 miRNA-200 100 64 ± 1.09** 70 ± 2.22** 79 ± 0.77** 84 ± 0.69*
12 miRNA-206 100 48 ± 0.98** 58 ± 1.98** 70 ± 1.41** 78 ± 0.91**
b Up-regulation
13 miRNA-499 100 127 ± 1.20** 122 ± 0.57** 144 ± 4.39** 132 ± 2.00**
II Inflammation
c Up-regulation
14 miRNA-373 100 176 ± 1.96** 164 ± 4.20** 136 ± 1.79** 132 ± 1.30**
15 miRNA-93 100 341 ± 3.38** 331 ± 4.14** 129 ± 2.50** 310 ± 5.12**
16 miRNA-192 100 362 ± 1.96** 229 ± 7.91** 357 ± 5.26** 282 ± 1.98**
17 miRNA-216a 100 367 ± 5.89** 220 ± 5.44** 319 ± 6.81** 177 ± 5.06**
18 miRNA-503 100 259 ± 4.77** 240 ± 4.93** 121 ± 1.29** 130 ± 3.11**
  Down-regulation
d
19 miRNA-101a 100 55 ± 1.20** 63 ± 2.18** 84 ± 1.06* 66 ± 1.37**
20 miRNA-125a 100 64 ± 1.85** 68 ± 1.22** 87 ± 0.79* 86 ± 1.60*
21 miRNA-155 100 23 ± 2.53** 66 ± 4.81** 57 ± 0.63** 26 ± 2.05**
22 miRNA-223 100 62 ± 2.36** 40 ± 5.06** 46 ± 1.44** 82 ± 1.81*
III Aging
e Down-regulation
23 miRNA-146a 100 21 ± 1.98** 44 ± 4.48** 33 ± 3.31** 26 ± 1.93**
* - **Values in a row sharing a common asterisk are significantly different at *P<0.01; **P<0.001.
The Effects of δ-tocotrienol on miRNAs-7a, miR-15a, miR-20a, miR-21, miR-29a, miR-92a, miR-200, miR-206 (in BJMMR. 2015; 6(4): 351-366), and miR-16-1, miR-125, miR-133a, miR-155, miR-223, miR-372, miR-10b, miR-18a, miR-214 (in JCEC. 2015; in press) have been reported. These miRNAs of δ-tocotrienol were included for comparison purpose only.
Table 6: The effects of various compounds on plasma circulating microRNAs (miRNA), the novel biomarkers for cardiovascular disease, cancer, diabetes, and aging process in normal cholesterolemic humans.